Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Galapagos initiates phase I trial with GLPG-3312

Jan. 7, 2019

Resolvin receptor analogues limit inflammation

Dec. 18, 2018

Anti-inflammatory compositions presented by House Wellness Foods, House Foods Group

Nov. 29, 2018

New anti-inflammation target has similarities, and differences, to PARP

Nov. 23, 2018

New path to RAS activation discovered

Nov. 23, 2018

The point of disorder

Nov. 21, 2018

ILDONG Pharmaceutical discovers farnesoid X receptor agonists

Nov. 2, 2018

Eiger's phase II study of ubenimex in lower leg lymphedema does not meet endpoints

Oct. 17, 2018

SHIP2 is key in FGF signaling and necessary for the maintenance of FGF-mediated ERK activation

Oct. 15, 2018

The flavonoid fisetin inhibits senescence and reduces age-related pathologies in elderly mice

Oct. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...